Engaging and Empowering Stakeholders to Advance Pharmacogenomics

Clin Pharmacol Ther. 2019 Aug;106(2):305-308. doi: 10.1002/cpt.1470. Epub 2019 Jun 26.

Authors

Karryn R Crisamore¹, Thomas D Nolin², James C Coons², Philip E Empey^{2

3}

Affiliations

¹ Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
² Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
³ Institute for Precision Medicine, University of Pittsburgh and UPMC, Pittsburgh, Pennsylvania, USA.

PMID: 31241758
DOI: 10.1002/cpt.1470

No abstract available

MeSH terms

Delivery of Health Care, Integrated* / organization & administration
Delivery of Health Care, Integrated* / standards
Humans
Medication Therapy Management* / organization & administration
Medication Therapy Management* / standards
Pharmacogenetics / methods*
Pharmacology, Clinical* / methods
Pharmacology, Clinical* / trends
Precision Medicine* / methods
Precision Medicine* / standards
Quality Improvement
Stakeholder Participation*